文献速递流行病学与生物统计临床试验与 GCP

适应性加权对数秩检验在生存结局临床试验中的期中监测

Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes.
PubMed 文献 · Stat Med · 2018-09-12

针对生存数据,传统对数秩检验在非比例风险情形下可能损失效能。Yang和Prentice提出的适应性加权对数秩检验可拓宽有效检验范围。本文建立该检验的期中监测流程,推导期中统计量的渐近分布,采用重抽样方法确定停止边界,并通过模拟和临床试验实例验证新方法在多种治疗效应模式下优于对数秩检验,且重抽样法对一类错误率控制更好。

要点

  • 适应性加权对数秩检验在非比例风险下较传统对数秩检验有更稳健的效能。
  • 期中监测采用重抽样法获取停止边界,无需两组删失分布相等假设。
  • 模拟研究显示新方法在宽泛治疗效应模式下改善对数秩检验并更好控制一类错误率。

核心结论

  • 适应性加权对数秩检验的期中监测流程在多种治疗效应模式下较传统对数秩检验提高效能。
  • 重抽样法所得临界值在两组删失分布不等时渐近有效。
  • 重抽样法对一类错误率的控制优于Yang和Prentice原方法。

研究设计与样本

  • 方法学研究,建立适应性加权对数秩检验的期中监测流程并推导期中统计量渐近分布。
  • 采用重抽样方法获取停止边界,通过局部备择假设下检验行为分析理论性质。
  • 开展广泛模拟研究并在多个临床试验实例中展示新流程。

主要发现

  • 在局部备择假设下,当两组极限删失分布相等时适应性加权对数秩检验完全有效。
  • 模拟研究表明新方法在宽泛治疗效应模式下改善对数秩检验。
  • 重抽样法较Yang和Prentice原方法更好控制一类错误率。

临床怎么用

  • 在生存结局临床试验的期中监测中,可考虑采用适应性加权对数秩检验以应对非比例风险。
  • 期中停止边界可通过重抽样方法确定,无需假设两组删失分布相等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

For testing treatment effect with survival data, the log-rank test has been the method of choice and enjoys an optimality property under proportional hazards alternatives. However, there can be significant loss of power in a variety of nonproportional situations. Yang and Prentice proposed an adaptively weighted log-rank test that improves the power of the log-rank test over a wide range of hazard ratio scenarios. In clinical trials, the data and safety monitoring board typically monitors the trial results periodically. Here, we develop interim testing procedures for the adaptively weighted log-rank test. We establish the asymptotic distribution of the test statistics at the interim looks and use a resampling method to obtain the stopping boundaries. Through examination of the test behavior under local alternatives, we show that the adaptively weighted log-rank test is fully efficient when the limiting censoring distributions in the two groups are equal. Unlike the case for the usual application of the log-rank test, critical values obtained from the resampling method are asymptotically valid without the assumption of equal censoring distributions in the two groups. Extensive simulation studies show that the new method improves the log-rank test for a wide range of treatment effect patterns, and that the resampling approach yields better control of the type 1 error rate than the originally proposed approach in the work of Yang and Prentice. The new procedures are illustrated in several clinical trial examples.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Yang S. Interim monitoring using the adaptively weighted log-rank test in clinical trials for survival outcomes. Stat Med. 2018. PMID: 30209818. doi:10.1002/sim.7958

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。